Compare BHE & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHE | FMC |
|---|---|---|
| Founded | 1979 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1990 | N/A |
| Metric | BHE | FMC |
|---|---|---|
| Price | $58.06 | $14.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 14 |
| Target Price | ★ $55.00 | $20.62 |
| AVG Volume (30 Days) | 306.9K | ★ 5.4M |
| Earning Date | 02-03-2026 | 02-04-2026 |
| Dividend Yield | 1.15% | ★ 2.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | $2,659,108,000.00 | ★ $3,467,400,000.00 |
| Revenue This Year | $5.71 | $8.64 |
| Revenue Next Year | $6.15 | $4.62 |
| P/E Ratio | $87.10 | ★ N/A |
| Revenue Growth | ★ 0.11 | N/A |
| 52 Week Low | $30.73 | $12.17 |
| 52 Week High | $60.51 | $44.78 |
| Indicator | BHE | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 71.83 | 44.76 |
| Support Level | $57.20 | $12.48 |
| Resistance Level | $60.51 | $16.75 |
| Average True Range (ATR) | 2.22 | 1.04 |
| MACD | 0.26 | -0.18 |
| Stochastic Oscillator | 80.59 | 45.61 |
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.